The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies

The Hung, Dang; Ghula, Suhaib; Muhamad Abdul Aziz, Jeza; M Makram, Abdelrahman; Mohamed Tawfik, Gehad; Ahmed‐Fouad Abozaid, Ali; Pancharatnam, Rohan; Mohamed Ibrahim, Amr; Besher Shabouk, Muhammad; Turnage, Morgan; Nakhare, Saloni; Karmally, Zahra; Kouz, Basel; Le, Tran; Alhijazeen, Suleiman; Quoc Phuong, Nguyen; Mohamed Ads, Alaa; Hussein Abdelaal, Ali; Hai Nam, Nguyen; Iiyama, Tatsuo; Kita, Kyoshi; Hirayama, Kenji; Tien Huy, Nguyen

doi:10.1016/j.ijid.2022.04.035

Public

The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies

Published in International Journal of Infectious Diseases • Apr 22, 2022

Authors:

Dang The Hung

Suhaib Ghula

Jeza Muhamad Abdul Aziz

Abstract

OBJECTIVES: This study aimed to evaluate the efficacy and adverse events of favipiravir in patients with COVID-19. METHODS: , 2022. Meta-analysis was done for randomized controlled trials (RCTs) and non-RCTs. RESULTS: Overall, 157 studies (24 RCTs, 1 non-RCT, 21 observational studies, 2 case series,...

Subject

Meta-analysis

Observational study

Favipiravir

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!